Olaparib 150 mg Manufacturers
Olaparib is a prescription anticancer medicine manufactured and marketed under different brand names by pharmaceutical companies in different countries.
For the products featured on Olaparib150mg.com, the relevant manufacturers are:
- Everest Pharmaceuticals Ltd. — Olanib 150 mg
- Ziska Pharmaceuticals Limited — Olakin 150 mg
Both products contain olaparib 150 mg as the active pharmaceutical ingredient.
Product availability, labeling, packaging, and regulatory status can vary by country. Patients should always check the actual product packaging and applicable local medicine information.
Everest Pharmaceuticals Ltd.
Everest Pharmaceuticals Ltd. is the pharmaceutical company associated with Olanib 150 mg, an olaparib 150 mg product.
The company has a pharmaceutical portfolio that includes medicines in several therapeutic areas, including oncology.
Olanib 150 mg is listed as an olaparib product within the company’s oncology portfolio.
Olanib 150 mg
Brand: Olanib
Generic name: Olaparib
Strength: 150 mg
Manufacturer: Everest Pharmaceuticals Ltd.
Olanib 150 mg is intended to provide olaparib in a 150 mg tablet strength for patients for whom olaparib has been appropriately prescribed.
The appropriate dose is determined by the treating healthcare professional and may differ from the strength of an individual tablet.
Why the Manufacturer Matters
The manufacturer is an important source of product-specific information.
Manufacturer information can help patients and healthcare professionals identify:
- Product name
- Active ingredient
- Strength
- Packaging
- Batch information
- Expiry information
- Storage requirements
- Authentication features
- Product-specific instructions
However, manufacturer information does not replace clinical advice from a qualified healthcare professional.
Manufacturer and Regulatory Approval
A pharmaceutical company’s product listing does not by itself determine whether a medicine is appropriate for a particular patient.
Olaparib is used for specific cancer indications and patient populations.
The approved indications, dosing recommendations, warnings, and treatment requirements can differ between regulatory jurisdictions.
Healthcare professionals should therefore consult the applicable current prescribing information when making treatment decisions.
Manufacturer and Product Quality
Pharmaceutical manufacturers are responsible for producing medicines according to applicable quality and regulatory requirements.
Patients should obtain prescription medicines through appropriate pharmaceutical supply channels.
If a product appears unusual, patients should not attempt to determine its quality solely from the tablet’s appearance.
Packaging, batch information, expiry date, supply source, and manufacturer verification information should also be considered.
What to Check When Receiving Olaparib
Whether receiving Olanib 150 mg or Olakin 150 mg, check:
Product Name
Confirm that the medicine supplied matches the name on the prescription.
Active Ingredient
Confirm that the product identifies olaparib as the active ingredient.
Strength
Confirm that the package states 150 mg if 150 mg tablets were prescribed.
Expiry Date
Do not use a medicine after its labeled expiry date.
Batch or Lot Number
Keep the batch or lot number available in case product verification or quality investigation is required.
Packaging
Check for damaged, opened, resealed, or unusual packaging.
Authentication Information
Use the manufacturer’s product-verification process when applicable.
Supply Source
Obtain prescription medicines from an appropriate and legitimate pharmaceutical source.
Manufacturer Information Does Not Replace Medical Advice
The manufacturer produces or supplies the medicine, but treatment decisions belong to the patient’s qualified healthcare team.
Questions such as the following should be directed to a doctor or pharmacist:
- Is olaparib appropriate for my cancer?
- What dose should I take?
- How long should treatment continue?
- Can I take olaparib with my other medicines?
- What should I do if I experience side effects?
- Should my treatment be interrupted?
- Do I need genetic or biomarker testing?
- How often should I have blood tests?
Do not use manufacturer product information alone to determine your personal treatment plan.
Olanib 150 mg and Olakin 150 mg
| Product | Active Ingredient | Strength | Associated Manufacturer |
|---|---|---|---|
| Olanib 150 mg | Olaparib | 150 mg | Everest Pharmaceuticals Ltd. |
| Olakin 150 mg | Olaparib | 150 mg | Ziska Pharmaceuticals Limited |
Both products contain the same generic active ingredient, but product-specific information may differ.
Always follow the information provided for the actual product supplied to you.
Product Packaging and Storage
Keep olaparib in the original packaging whenever possible.
Follow the storage instructions provided on the specific product packaging.
Do not use tablets that are damaged, broken, unusually discolored, or otherwise appear abnormal without consulting a pharmacist.
Keep the medicine out of reach of children.
Reporting Product Problems
If you believe a medicine has a quality problem, retain:
- The medicine
- Original packaging
- Batch or lot number
- Expiry date
- Verification information
- Purchase or supply information where available
Contact an appropriate pharmacist, authorized supplier, or manufacturer.
If you experience a suspected adverse drug reaction, also inform your healthcare professional.
Choosing a Reliable Pharmaceutical Source
Prescription medicines should be obtained through appropriate pharmaceutical channels.
Be cautious if a seller:
- Does not require appropriate prescription information
- Cannot identify the manufacturer
- Provides damaged packaging
- Refuses to provide batch information
- Offers suspiciously low pricing
- Cannot explain product verification
- Provides tablets without appropriate labeling
A legitimate product should be accompanied by appropriate identification and packaging information.
International Availability
Olaparib products may be available under different brand names in different countries.
The existence of a particular brand or manufacturer in one country does not necessarily mean that the product is approved or marketed in another country.
Patients should use medicines according to local prescribing requirements and applicable regulatory approvals.
Important Distinction Between Generic and Brand Name
Olaparib is the generic name of the active pharmaceutical ingredient.
Olanib and Olakin are brand names associated with 150 mg olaparib products featured on this website.
Brand names can differ between manufacturers and countries.
The presence of the same active ingredient does not mean that patients should switch products without confirming the change with a healthcare professional or pharmacist.
Patients should verify the medicine they receive, retain its original packaging, follow the manufacturer’s product information, and use the medicine only as prescribed.
For questions concerning treatment suitability, dosage, interactions, side effects, or treatment duration, consult your oncologist or pharmacist.